jprattes Profile Banner
Jürgen Prattes Profile
Jürgen Prattes

@jprattes

Followers
322
Following
2K
Media
13
Statuses
457

M.D., FECMM | ID consultant | deep interest in clinical research focused on fungal infections | President of the Austrian Society of Medical Mycology (ÖGMM)

Graz, Austria
Joined October 2009
Don't wanna be here? Send us removal request.
@jprattes
Jürgen Prattes
2 months
First retreat of our translational mycology working group 🍄👨🏼‍💻👩‍💻. Shaping future research topics and study designs in medical mycology 🦾.@martinhoenigl @SarahSedik @Stella_A_I
Tweet media one
0
3
12
@jprattes
Jürgen Prattes
4 months
RT @SarahSedik: Join our Global ECMM Candida IV Study 🍄. @eurconfmedmycol .@EcmmCandidaIV .@martinhoenigl .@Stella_A_I . #ESCMIDGlobal2025….
0
6
0
@jprattes
Jürgen Prattes
5 months
Fully packed 2nd symposium of the austrian society of medical mycology (ÖGMM) - thanks to all speakers and participants for the interactive sessions
Tweet media one
Tweet media two
0
5
13
@jprattes
Jürgen Prattes
9 months
RT @martinhoenigl: 👉Participate in ECMM Candida IV. 🌎wide study on candidemia caused by non-albicans Candida spp. Requirement: clinical da….
0
8
0
@jprattes
Jürgen Prattes
9 months
RT @eurconfmedmycol: Proud of the results of a fantastic collaboration with @MSG_ERC . We invite all our followers and members to review an….
0
7
0
@jprattes
Jürgen Prattes
9 months
RT @MSG_ERC: Along w/ @eurconfmedmycol, we are seeking public comments on revised clinical outcome criteria for aspergillosis & other mold….
0
18
0
@jprattes
Jürgen Prattes
1 year
RT @martinhoenigl: Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients @s_feys @carvalho_ago @C….
0
15
0
@jprattes
Jürgen Prattes
1 year
Posa prophylaxis to prevent CAPA? Yes for centers with high-baseline CAPA rates and targeted in high-risk patients (e.g. EORTC risk factors present), no for others. @martinhoenigl @danieleroberto4 @ProfMBassetti @GangneuxJp.
0
4
13
@jprattes
Jürgen Prattes
1 year
RT @yourICM: 🍄Antifungal prophylaxis of #COVID19 associated pulmonary aspergillosis in pts on MV. Significant variation in CAPA incidence a….
0
9
0
@jprattes
Jürgen Prattes
1 year
RT @robertpdickson: Most patients with sepsis don't need anti-anaerobic antibiotics. But most get them anyway. Why not, what's the harm?. I….
0
252
0
@jprattes
Jürgen Prattes
1 year
RT @YoungECMM: Our #ECCMID2024 get-together will take place at.🚩Alice Secret Garden 📋RSVP still online https://t.co….
0
12
0
@jprattes
Jürgen Prattes
1 year
RT @martinhoenigl: 🔥📰from CMR:.Novel antifungals and Tx approaches to tackle resistance and improve outcomes of invasive fungal disease. @A….
Tweet card summary image
journals.asm.org
SUMMARYFungal infections are on the rise, driven by a growing population at risk and climate change. Currently available antifungals include only five classes, and their utility and efficacy in...
0
28
0
@jprattes
Jürgen Prattes
1 year
RT @YoungECMM: Are you under 40 years of age and want to be part of an international program in your early career in mycology?.➡️Join @Youn….
Tweet card summary image
ecmm.info
Welcome to the Young ECMM programme Become the face of the next generation in medical mycology, become a Young ECMM fellow. Be part of the international programme in your early career in mycology to...
0
16
0
@jprattes
Jürgen Prattes
1 year
#ÖGMM-Symposium zu invasive Mykosen am 09.04.24🍄im Hotel Brandlhof. Ab 13:30h (fast) alles Wissenswerte über Pilzinfektionen --> Keine Registrierung, keine Gebühren. Einfach teilnehmen 🥳🧐.@martinhoenigl @RobertK05753862 und viele weitere Expert:innen!.
0
2
6
@jprattes
Jürgen Prattes
1 year
RT @YoungECMM: YECMM is planning a 🍄 get-together during #ECCMID2024 ! Are you a young clinician/scientist interested in mycology ? .Join u….
0
14
0
@jprattes
Jürgen Prattes
2 years
CAPA in Patients Admitted to the Intensive Care Unit: Impact of Antifungal Prophylaxis. Posaconazole ⬇️CAPA incidence rate at our center. Future trials will focus on a more nuanced, risk-factors based prophylactic approach. @martinhoenigl @reisinger_alex .
0
7
20
@jprattes
Jürgen Prattes
2 years
Risk of COVID-19-associated pulmonary aspergillosis: time for a nuanced approach to antifungal prophylaxis? Learning about the individual risk for #CAPA development will allow for a more individualized #COVID19 management @martinhoenigl @LancetRespirMed.
Tweet card summary image
thelancet.com
COVID-19-associated pulmonary aspergillosis (CAPA) emerged as a serious complication of severe COVID-19 during the early phases of the COVID-19 pandemic.1 Although absolute numbers of CAPA have...
1
14
30